Form 4: CompuGen Ltd. Executive Trades Ordinary Shares

Zurit Levine, SVP of Business Development at CompuGen Ltd., executed trades involving ordinary shares and stock options under a Rule 10b5-1 plan.

Summary

• Zurit Levine, Senior Vice President of Business Development at CompuGen Ltd., reported transactions involving the company's ordinary shares and stock options.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on December 23, 2025.
• Levine acquired 2,500 ordinary shares at $0.8292 on April 7, 2026, and an additional 4,375 ordinary shares at $0.8292 and 1,000 ordinary shares at $1.15 on April 8, 2026.
• Concurrently, Levine disposed of 2,500 ordinary shares at $2.3 on April 7, 2026, and 5,375 ordinary shares at $2.42 on April 8, 2026.
• The filing also details the acquisition and disposal of stock options related to these transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions under a pre-established plan rather than indicating significant company performance changes or strategic shifts.

Positives

• The executive is actively managing their holdings through a pre-planned Rule 10b5-1 trading plan, which can provide a defense against insider trading allegations.
• Acquisition of shares at a lower price point ($0.8292) could be seen as a positive indicator if the stock price subsequently rises.

Negatives

• Disposal of ordinary shares at higher prices ($2.3 and $2.42) indicates the executive is realizing gains on their holdings.
• The net effect of the transactions shows a reduction in directly held ordinary shares.

Risks

• The Rule 10b5-1 plan itself is subject to specific requirements, and any deviation or misinterpretation could lead to regulatory scrutiny.
• The disposal of shares, even under a plan, could be interpreted negatively by the market if not accompanied by other positive company news.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions executed under a Rule 10b5-1 plan.

Management Comments

• The transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.
• Option vesting schedules are detailed, contingent on continued service to the Issuer.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executives and directors, providing transparency into their stock transactions. The use of a Rule 10b5-1 plan is a common strategy for insiders to diversify holdings or manage liquidity without creating the appearance of trading on material non-public information.

Stakeholder Impact

• Shareholders: Increased transparency into executive stock transactions, potentially influencing market perception based on the volume and timing of disposals.
• Employees: May observe executive's confidence in the company based on share acquisitions, though disposals could be viewed neutrally given the Rule 10b5-1 plan.
• Management: Demonstrates adherence to compliance protocols for insider trading regulations through the use of a Rule 10b5-1 plan.

Next Steps

• Continued adherence to the Rule 10b5-1 trading plan for future transactions, if applicable.
• Monitoring of CompuGen Ltd.'s stock performance and future SEC filings for further executive or company disclosures.

Key Dates

Keywords

Form 4, SEC Filing, CompuGen Ltd., CGEN, Insider Trading, Stock Options, Ordinary Shares, Rule 10b5-1, Beneficial Ownership, Securities Transaction